The treatment of systemic lupus proliferative nephritis
- First Online:
- Cite this article as:
- Punaro, M.G. Pediatr Nephrol (2013) 28: 2069. doi:10.1007/s00467-012-2327-1
- 1.5k Downloads
Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus (SLE) in childhood affecting more than 80 % of patients. Treatment of this complication has undergone significant evolution in recent years. A series of randomized controlled trials has clarified the role of a variety of immunomodulating regimens including some novel biologic medications. This review touches on the major trials that have influenced practice and shaped current thinking about the treatment of proliferative lupus glomerulonephritis.